Position in INCY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$21,687,128
-$13,540,105 QoQ
Shares Held
191,312
-48.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#110
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. INCY ranks #4 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
This page
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,687,128 | 191,312 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $35,227,233 | 374,280 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $28,305,999 | 286,585 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $27,705,815 | 326,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,368,108 | 137,564 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,357,023 | 104,988 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,771,341 | 112,514 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,275,758 | 110,072 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,702,328 | 110,563 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $43,890,484 | 770,414 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,015,833 | 127,661 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,567,920 | 200,241 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,844,275 | 158,141 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,519,331 | 159,393 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,596,745 | 156,832 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,401,437 | 156,084 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $12,087,509 | 159,109 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,677,337 | 159,624 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $18,763,168 | 255,629 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,950,875 | 159,216 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,311,047 | 158,220 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,273,693 | 175,633 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $12,866,512 | 147,925 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $987 | 11 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $20,170 | 194 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $14,572 | 199 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||